MacroGenics, Inc.
Compound targeting IL-23A and TNF-alpha and uses thereof
Last updated:
Abstract:
The disclosure relates to compounds specific for IL23A and TNF-alpha, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
1 Aug 2018
Issue date:
6 Oct 2020